Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Supernus Pharmaceuticals
Pharma
Beleaguered Sage bought for $561M
Supernus is buying Sage Therapeutics for $561 million, hoping that it can transform a new postpartum depression drug into a “standard of care."
Kevin Dunleavy
Jun 16, 2025 11:52am
Supernus casts Busy Philipps in Qelbree push for women with ADHD
May 21, 2025 10:52am
Supernus' Parkinson's pump Onapgo finally lands FDA approval
Feb 4, 2025 4:32pm
FDA again rejects Supernus' Parkinson's disease pump
Apr 8, 2024 10:15am
Infusion device issues sink Supernus' Parkinson's filing
Oct 10, 2022 11:07am
FDA approves Qelbree, a nonstimulant, for adults with ADHD
May 2, 2022 3:10pm
